Biotech RadarJobs updated

COMPANY

URO-1

HQ: Greensboro, NC source · uro1medical.com ↗

FDA-cleared device company

Location: Greensboro, NC · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Prostate Cancer Screening Prostate Disease Prostate CA Overactive Bladder Syndrome Prostate Cancer Repris Needle

5Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis source ↗
  2. Trial start Not phased (device or behavioral study): Evaluation of SureCore Plus Biopsy System source ↗
  3. Trial start Not phased (device or behavioral study): Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue Parameters source ↗
  4. Trial start Not phased (device or behavioral study): Assessment of VMCore Biopsy Versus Standard of Care Biopsy source ↗
  5. Trial start Not phased (device or behavioral study): Use of Repris Needle in Bladder Injection source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06830265Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic AnalysisNot phased (device or behavioral study)RecruitingJul 7, 2025Nov 1, 2026 (estimated)
NCT05470127Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue ParametersNot phased (device or behavioral study)RecruitingAug 1, 20222025-10 (estimated)
NCT06550960Evaluation of SureCore Plus Biopsy SystemNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Aug 5, 2024Dec 31, 2024 (estimated)
NCT04982120Use of Repris Needle in Bladder InjectionNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Oct 15, 2018Jun 14, 2022 (estimated)
NCT04982536Assessment of VMCore Biopsy Versus Standard of Care BiopsyNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Jul 19, 2020Jul 1, 2022 (estimated)
Feedback